HIV and AIDS Research News & Events

A NCI and NIAID supported clinical trial for Kaposi sarcoma (KS) suggests that paclitaxel  is a superior treatment when compared to bleomycin and vincristine with ART or oral etoposide with ART for patients with advanced KS in low resource settings. 

June 2018 

Investigators at the Center for Cancer Research, NCI describe how different simian immunodeficiency virus (SIV) vaccines respond differently to outside stimuli.  The activation of hypoxia and the inflammasome in CD14+ monocytes result in a decrease risk of SIV acquisition.

Nature Medicine

May 2018

Investigators at NCI identify the receptor for one of the HLA proteins (HLA-E) as a potential new target for HIV treatment. Blockade of this pathway has been implicated in many cancers and autoimmune diseases.

Science

January 2018

People living with HIV have an increased cancer burden, even in the absence of over immunosuprresion. In this review, NCI researchers Drs. Yarchoan and Uldrick describe the current epidemiology, pathogenesis and prevention strategies of HIV-associated cancers and related diseases.

New England Journal of Medicine

March 2018

NCI supported researchers have determined the structure of the Kaposi sarcoma-associated herpesvirus (KSHV), also called human herpesvirus 8.  This may provide a target for the developement of antiviral agents.

Nature

January 2018

October 2017

NIH Campus, Bethesda, MD, USA

October 21-22, 2019

June 30-July 3, 2019

New York City, USA

Abstract Submission Deadline

March 25, 2019